Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 2200 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 2000 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1900 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1800 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1700 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1600 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1500 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1400 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1300 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - gemcitabine hydrochloride, quantity: 1200 mg - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic non-small cell lung cancer. gemcitabine sun 10mg/ml solution for infusion is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine sun 10mg/ml solution for infusion is also indicated for patients with 5-fu refractory pancreatic cancer. gemcitabine sun 10mg/ml solution for infusion, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer. gemcitabine sun 10mg/ml solution for infusion, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. gemcitabine sun 10mg/ml solution for infusion, in combination with carboplatin, is indicated for the treatment of pa